Patient Prognosis

The most common causes of death are respiratory failure and liver cirrhosis. Beyond the usual treatment of COPD, specific treatment consists of the infusion of purified pooled human plasma α1-antitrypsin, known as intravenous augmentation therapy. It has shown a clear efficacy in randomized, double-blind, placebo-controlled trials.

References

1. Kulwiec EL, Lynch DA, Aguayo SM, Schwarz MI, King Jr TE. Imaging of pulmonary histiocytosis X. Radiographics. 1992;12:515–26.

2. Aberle DR, Gamsu G, Lynch D. Thoracic manifestations of Wegener granulomatosis: diagnosis and course. Radiology. 1990; 174:703–9.

3. Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology. 1994;193:375–82.

4. Davis SD. CT evaluation for pulmonary metastases in patients with extrathoracic malignancy. Radiology. 1991;180:1–12.

5. Iwasaki Y, Nagata K, Nakanishi M, et al. Spiral CT findings in septic pulmonary emboli. Eur J Radiol. 2001;37:190–4.

6. Kim HJ, Lee KS, Johkoh T, et al. Pulmonary Langerhans cell histiocytosis in adults: high-resolution CT-pathology comparisons and evolutional changes at CT. Eur Radiol. 2011;21:1406–15.

7. Seo JB, Im JG, Goo JM, Chung MJ, Kim MY. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics. 2001;21:403–17.

8. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10–2001. A 53-year-old woman with arthritis and pulmonary nodules. N Engl J Med. 2001;344: 997–1004.

9. Antin-Ozerkis D, Evans J, Rubinowitz A, Homer RJ, Matthay RA. Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med. 2010;31:451–78.

10.Capobianco J, Grimberg A, Thompson BM, Antunes VB, Jasinowodolinski D, Meirelles GS. Thoracic manifestations of collagen vascular diseases. Radiographics. 2012;32:33–50.

11.Kobayashi T, Satoh K, Ohkawa M, Satoh A. Multiple rheumatoid nodules with rapid thin-walled cavity formation producing pneumothorax. J Thorac Imaging. 2005;20:47–9.

12.Kitamura A, Matsuno T, Narita M, Shimokata K, Yamashita Y, Mori N. Rheumatoid arthritis with diffuse pulmonary rheumatoid nodules. Pathol Int. 2004;54:798–802.

13.Chaudhuri MR. Cavitary pulmonary metastases. Thorax. 1970;25: 375–81.

14.Hirakata K, Nakata H, Nakagawa T. CT of pulmonary metastases with pathological correlation. Semin Ultrasound CT MR. 1995;16: 379–94.

15.Murata K, Takahashi M, Mori M, et al. Pulmonary metastatic nodules: CT-pathologic correlation. Radiology. 1992;182:331–5.

16.Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246:697–722.

17.Beddy P, Babar J, Devaraj A. A practical approach to cystic lung disease on HRCT. Insights Imaging. 2011;2:1–7.

18.Seaman DM, Meyer CA, Gilman MD, McCormack FX. Diffuse cystic lung disease at high-resolution CT. AJR Am J Roentgenol. 2011;196:1305–11.

19.McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest. 2008;133:507–16.

20.Traweek T, Rotter AJ, Swartz W, Azumi N. Cystic pulmonary metastatic sarcoma. Cancer. 1990;65:1805–11.

21.Kumasaka T, Seyama K, Mitani K, et al. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis. Am J Surg Pathol. 2004;28: 1007–16.

22.Johnson SR, Cordier JF, Lazor R, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010;35:14–26.

23.Muller NL, Chiles C, Kullnig P. Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology. 1990;175:335–9.

24.McCormack FX, Inoue Y, Moss J, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011;364: 1595–606.

25.American Thoracic S, European RS. American Thoracic Society/ European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165: 277–304.

26.Tian X, Yi ES, Ryu JH. Lymphocytic interstitial pneumonia and other benign lymphoid disorders. Semin Respir Crit Care Med. 2012;33:450–61.

27.Johkoh T, Muller NL, Pickford HA, et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology. 1999;212:567–72.

28.Ichikawa Y, Kinoshita M, Koga T, Oizumi K, Fujimoto K, Hayabuchi N. Lung cyst formation in lymphocytic interstitial pneumonia: CT features. J Comput Assist Tomogr. 1994;18: 745–8.

29.Kim AY, Lee KS, Han J, Kim H, Kim K, Baek CH. Cystic pulmonary metastasis in a patient with scalp angiosarcoma: a case report. J Korean Soc Radiol. 2011;65:143–6.

30.Garcia Clemente M, Gonzalez Budino T, Escobar Stein J, Seco Garcia AJ, Celorio Peinado C, Rodriguez RJ. Metastatic pulmonary angiosarcoma. An Med Interna. 2004;21:27–30.

31.Park SI, Choi E, Lee HB, Rhee YK, Chung MJ, Lee YC. Spontaneous pneumomediastinum and hemopneumothoraces secondary to cystic lung metastasis. Respiration. 2003;70:211–3.

32.Thurlbeck WM, Muller NL. Emphysema: definition, imaging, and quantification. AJR Am J Roentgenol. 1994;163:1017–25.

33.Foster Jr WL, Gimenez EI, Roubidoux MA, et al. The emphysemas: radiologic-pathologic correlations. Radiographics. 1993;13: 311–28.

34.Madani A, Zanen J, de Maertelaer V, Gevenois PA. Pulmonary emphysema: objective quantification at multi-detector row CT– comparison with macroscopic and microscopic morphometry. Radiology. 2006;238:1036–43.

35.Zaporozhan J, Ley S, Eberhardt R, et al. Paired inspiratory/expiratory volumetric thin-slice CT scan for emphysema analysis: comparison of different quantitative evaluations and pulmonary function test. Chest. 2005;128:3212–20.

36.Gelb AF, Schein M, Kuei J, et al. Limited contribution of emphysema in advanced chronic obstructive pulmonary disease. Am Rev Respir Dis. 1993;147:1157–61.

37.Park YS, Seo JB, Kim N, et al. Texture-based quantification of pulmonary emphysema on high-resolution computed tomography: comparison with density-based quantification and correlation with pulmonary function test. Invest Radiol. 2008;43:395–402.

38.Matsuoka S, Yamashiro T, Washko GR, Kurihara Y, Nakajima Y, Hatabu H. Quantitative CT assessment of chronic obstructive pulmonary disease. Radiographics. 2010;30:55–66.

39.Mets OM, de Jong PA, van Ginneken B, Gietema HA, Lammers JW. Quantitative computed tomography in COPD: possibilities and limitations. Lung. 2012;190:133–45.

40.The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis. 1985;32:182–5.

41.Foster Jr WL, Pratt PC, Roggli VL, Godwin JD, Halvorsen Jr RA, Putman CE. Centrilobular emphysema: CT-pathologic correlation. Radiology. 1986;159:27–32.

42.Stoller JK, Aboussouan LS. A review of alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185:246–59.

43.Spouge D, Mayo JR, Cardoso W, Muller NL. Panacinar emphysema: CT and pathologic findings. J Comput Assist Tomogr. 1993;17:710–3.